Reduced fluence corneal cross-linking in mild to moderate keratoconus: One year-follow-up.

Abstract

PURPOSE:

To evaluate the safety and efficacy of reduced fluence CXL (lower dose of UV-A irradiation) in mild to moderate keratoconus.

SETTING:

Farabi Eye Hospital, Tehran, Iran.

DESIGN:

Non-randomized prospective comparative interventional case series. Every eligible patient included in the study (mild to moderate progressive keratoconus) was randomly allocated to case (reduced fluence) and control (standard) groups, except for bilateral patients. In these patients the eye with more advanced disease was allocated to control group and the other eye was randomly assigned in either case or control group. Operators performing refraction and images and the data analyst were masked, but patients and physicians were not.

METHODS:

Forty-six eyes of 38 patients were recruited. Group 1 received 7 min (fluence of 3.8 J/cm2), while group 2 received 10 min of 9 mW/cm2 UV-A (fluence of 5.4 J/cm2). Visual, keratometric and biomechanical outcomes were compared between groups.

RESULTS:

At last follow-up (mean12 months, range 6-24 months), there were no statistically significant differences in changes in uncorrected visual acuity, best corrected distance visual acuity, Kmax, Kmean, corneal hysteresis, corneal resistance factor, endothelial cell counts, demarcation line depth, and intraoperative pain scores between groups (all p-values < 0.05).

CONCLUSION:

The results of this study show comparable one-year outcomes between 3.8 and 5.4 J/cm2 accelerated CXL in mild to moderate keratoconus. Should the results of this study be confirmed in longer follow-ups, using a reduced fluence setting could be considered as an alternative to standard treatment in these patients.

• Authors: Seyed Reza Ghaffari, Saeed Khaheshi, Fateme Alipour, Somayye Mashhadi Farahani, Amir-Hooshang Beheshtnejad, Farhad Hafezi
• Journal: European journal of ophthalmology (Eur J Ophthalmol) Vol. 31 Issue 5 Pg. 2206-2212 (Sep 2021) ISSN: 1724-6016 [Electronic] United States
• PMID: 33092399 (Publication Type: Journal Article)

Chemical References

• Cross-Linking Reagents
• Photosensitizing Agents
• Collagen
• Riboflavin

Topics

• Collagen (therapeutic use)
• Corneal Topography
• Cross-Linking Reagents (therapeutic use)
• Follow-Up Studies
• Humans
• Iran
• Keratoconus (drug therapy)
• Photochemotherapy
• Photosensitizing Agents (therapeutic use)
• Prospective Studies
• Riboflavin (therapeutic use)
• Ultraviolet Rays